|
2023
|
Invention
|
Camptothecin prodrug and pharmaceutical composition thereof.
Disclosed are a compound of Formula... |
|
|
Invention
|
Camptothecin prodrug and pharmaceutical composition thereof. 12345678910111213141515 are as defin... |
|
|
Invention
|
Camptothecin prodrug and pharmaceutical composition thereof. Disclosed are a compound of general ... |
|
2017
|
Invention
|
Tetracyclic anthraquinone derivatives. Disclosed are a compound represented by formula (I) and a ... |
|
|
Invention
|
Cyanoquinoline derivatives. Disclosed is a compound of formula I, a stereoisomer thereof, a cis-t... |
|
2014
|
Invention
|
Quinazoline derivative. Disclosed are N-[4-(3-chloro-4-fluorophenylamino)-7-(2-methoxyethoxy) qui... |
|
|
Invention
|
Quinazoline derivative.
Disclosed are N-[4-(3-chloro-4-fluorophenylamino)-7-(2-methoxy... |
|
2012
|
Invention
|
Methods of preparing and using quinazoline and quinoline derivatives. A method of preparing a com... |
|
2011
|
Invention
|
Cyanoquinoline derivatives.
The present invention provides compounds of general formul... |
|
2010
|
Invention
|
Pyridyl cyanoguanidine derivatives. 2 and n are described in description.
|
|
|
Invention
|
Quinazoline and quinoline derivatives as irreversibe protein tyrosine kinase inhibitors. A compou... |
|
2009
|
Invention
|
Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the sa... |
|
2008
|
Invention
|
Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors. A compo... |
|
2007
|
Invention
|
Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof.
|
